Malignant Prostate Neoplasm — Trials

Malignant Prostate Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

5,981 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 1,377
Recruiting: 745
Ph III recruiting: 79
Growth YoY: +22.3%
Industry share: 19%
Top sponsor: M.D. Anderson Cancer Center
Termination share: 27%
Trials / 1,000 deaths: 40.6 USA 2023 cdc-uscs

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (730)

clinicaltrialsPublishedShowing 651–700 of 978 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06866938	Study of Re-treatment With [177Lu]Lu-PSMA in Men With Metastatic Castration Resistance Prostate Cancer(ReaLuP)	recruiting	Phase 2	58	Hospices Civils de LyonOTHER	1	Jan 6, 2026	clinicaltrials
NCT07319923	Establishment and Promotion of an AI-Based Early Warning System for Prostate and Bladder Cancer Screening in the Male Community Population of Beijing	recruiting	—	3,000	Peking University First HospitalOTHER	1